Search by Drug Name or NDC

    NDC 51407-0261-30 Olanzapine 5 mg/1 Details

    Olanzapine 5 mg/1

    Olanzapine is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Golden State Medical Supply, Inc.. The primary component is OLANZAPINE.

    Product Information

    NDC 51407-0261
    Product ID 51407-261_0d82ec9b-3d72-1741-e063-6394a90a95c5
    Associated GPIs 59157060007210
    GCN Sequence Number 045190
    GCN Sequence Number Description olanzapine TAB RAPDIS 5 MG ORAL
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 92007
    HICL Sequence Number 011814
    HICL Sequence Number Description OLANZAPINE
    Brand/Generic Generic
    Proprietary Name Olanzapine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Olanzapine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name OLANZAPINE
    Labeler Name Golden State Medical Supply, Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091265
    Listing Certified Through 2024-12-31

    Package

    NDC 51407-0261-30 (51407026130)

    NDC Package Code 51407-261-30
    Billing NDC 51407026130
    Package 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (51407-261-30)
    Marketing Start Date 2019-10-16
    NDC Exclude Flag N
    Pricing Information N/A